Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06348589
Other study ID # 2023-05959-01
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date April 2024
Est. completion date September 2024

Study information

Verified date March 2024
Source Vrinnevi Hospital
Contact Magnus O Wijkman, MD, PhD
Phone 00461040000
Email magnus.wijkman@liu.se
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

High blood pressure is a risk factor for end-stage renal disease and is common in patients undergoing maintenance hemodialysis. Intradialytic hypotension is associated with an adverse prognosis. More knowledge is needed to identify patients at high risk for intradialytic hypotension and dialysis-associated hypotensive episodes. The aim of this observational single-center pilot study is to evaluate whether point-of-care ultrasound measurements may predict intradialytic hypotension and orthostatic blood pressure falls, in patients with chronic kidney disease who undergo maintenance hemodialysis.


Description:

Background: Hypertension is an independent risk factor for development of end-stage renal disease and is the leading risk factor for cardiorenal death. It is estimated that more than 80% of patients with end-stage renal disease who undergo maintenance hemodialysis have hypertension. Intensified blood pressure control has been associated with reduced risk of death in patients with hypertension and chronic kidney disease but may increase the risk for intra-dialytic blood pressure falls in patients who undergo hemodialysis. Hemodialysis-associated hypotension has been associated with increased risks for cardiovascular disease and mortality. Aim: The aim of this observational pilot study is to evaluate whether point-of-care ultrasound measurements may predict intradialytic hypotension and orthostatic blood pressure falls, in patients with chronic kidney disease who undergo maintenance hemodialysis. Ethics: The study has been approved by the Swedish Ethical Review Authority (2023-05959-01). Study participants: All patients (n=70) with chronic kidney disease who undergo maintenance hemodialysis at Vrinnevi Hospital in Norrköping, Sweden, will be invited to voluntarily participate in the study. Information about the study will be given orally and in written form. Those who opt to participate will be asked to sign a written informed consent. Background data collection: For descriptive purposes, information will be collected regarding current and prior medical diagnoses, current medical treatment, anthropometric data, and self-perceived quality of lite (using the validated questionnaire KDQOL-SF). Blood samples will be tested for routine hematological variables, as well as for sodium, potassium, calcium, creatinine, urea and HbA1c. Ultra-sound measurements: Before initiation of dialysis, point-of-care ultrasound measurements will be performed with the patient resting in a supine position at a 30 degrees angle, using a Sonosite SII ultrasound machine with a curvilinear probe. Measurements of the diameter of the inferior vena cava will be performed at a level approximately 2 cm from the right atrium, and breathing variability of its diameter will be assessed. Blood pressure measurements: Systolic and diastolic blood pressure measurements will be performed after the patient has been resting for 5 minutes in the supine position, with a cuff size that is appropriate for each patient, with the arm resting at heart level, in the arm where the patient does not have a dialysis fistula, using an automated blood pressure measurement device (Fresenius 6008 CARE System) which is connected to the dialysis equipment. Two measurements (with one minute apart) will be performed 30 minutes before the dialysis session begins, three measurements will be performed after half of the planned dialysis session, and two measurements will be performed 15 minutes after the dialysis session has ended. An orthostatic test, which includes systolic and diastolic blood pressure measurements taken immediately after standing up and 1 and 3 minutes after standing up, will also be performed 30 minutes before the dialysis session begins and 15 minutes after the dialysis session has ended. Statistics: Background information (demographics, anthropometrics, medical history, medication, biochemical evaluation) will be presented for the entire study population as means with standard deviations, medians with inter-quartile ranges, or as counts with percentages, as appropriate. These variables will also be presented in patients with and without intradialytic blood pressure falls (defined as an intradialytic reduction of systolic blood pressure ≥ 20 mmHg or of diastolic blood pressure ≥10 mmHg), and in patients with and without orthostatic blood pressure falls (defined as an orthostatic reduction of systolic blood pressure ≥ 20 mmHg or of diastolic blood pressure ≥10 mmHg), respectively. Between-group differences will be tested for statistical significance using Student´s t-test, Mann-Whitney U-test, Chi-square test or Fisher´s exact test, as appropriate. Temporal changes in supine systolic and diastolic blood pressures (assessed prior to dialysis, during dialysis and after dialysis) will be visualized with regression slopes, and mixed models will be used to assess their associations with ultrasound measurements of the inferior vena cava. Associations between ultrasound measurements of the inferior vena cava and the blood pressure changes during the orthostatic blood pressure tests will be visualized with scatter plots and tested for statistical significance with correlation analysis. The predictive ability of ultrasound measurements of the inferior vena cava and the occurrence of intra-dialytic blood pressure falls and of orthostatic blood pressure falls, respectively, will be assessed with logistic regression.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date September 2024
Est. primary completion date September 2024
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patient undergoing hemodialysis treatment at Vrinnevi Hospital, Norrköping Sweden - Provision of written informed consent - Ability to understand instructions and to participate in the investigations Exclusion Criteria: - Ongoing acute illness - Hospitalization within 4 weeks prior to enrollment - Unability to provide informed consent

Study Design


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Vrinnevi Hospital Linkoeping University

Outcome

Type Measure Description Time frame Safety issue
Primary Intra-dialytic systolic blood pressure fall of 20 mmHg or larger Difference between pre-dialytic and intra-dialytic systolic blood pressure Up to 1 week
Primary Post-dialytic orthostatic systolic blood pressure fall of 20 mmHg or larger Change between supine and upright systolic blood pressure Up to 1 week
See also
  Status Clinical Trial Phase
Completed NCT05700851 - Immuno-nutrition Supplementation in Haemodialysis N/A
Recruiting NCT02616627 - Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
Completed NCT01464190 - A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients Phase 3
Recruiting NCT06040281 - Smart and Fit for Kidney Transplantation N/A
Active, not recruiting NCT03535922 - Evaluation of Routinely Measured Patient-reported Outcomes in Hemodialysis Care N/A
Completed NCT04622709 - Pilot Study of Loop Diuretics Among Individuals Receiving Hemodialysis Phase 2
Completed NCT04585607 - Potential Benefits of Expanded Hemodialysis in Prevention of Sarcopenia Phase 4
Completed NCT03182699 - Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients Phase 4
Completed NCT03942744 - The Effect of High-flux Hemodialysis and On-line Hemodiafiltration on Endothelial Function. N/A
Completed NCT04549597 - Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia Phase 4
Recruiting NCT04659525 - Evolocumab Plus Ezetimibe in Haemodialized Statin-intolerant Patients With Hypercholesterolemia Phase 4
Completed NCT04125537 - Pathways Project: Kidney Supportive Care
Recruiting NCT03347773 - Oral Nutritional Supplement Intervention Among Hemodialysis Patients With Sarcopenic Obesity N/A
Recruiting NCT04397653 - Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients Phase 4
Active, not recruiting NCT03938285 - Effect of Hemodiafiltration Plus MCOs on Uremic Toxins Removal N/A
Completed NCT03525223 - Modulation of Tissue Sodium in Hemodialysis Patients N/A
Completed NCT01324128 - A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients Phase 3
Not yet recruiting NCT04600193 - a Randomized Controlled Trial of the Intake of Organic and Inorganic Phosphate in Peritoneal Dialysis Patients N/A
Not yet recruiting NCT06225544 - Lumasiran in Hyperoxalaemic Patients on Haemodialysis Phase 2
Recruiting NCT05209880 - Advance Care Planning in the Emergency Department N/A